← Browse by Condition
Medical Condition
idh mutation
Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for idh mutation sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — idh mutation Clinical Trials
How many clinical trials are currently recruiting for idh mutation?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for idh mutation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for idh mutation?
idh mutation research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a idh mutation clinical trial?
Eligibility criteria for idh mutation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT04233788
Recruiting
Metabolic Characterization of Space Occupying Lesions of the Brain
Enrollment
55 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
NCT06636162 EARLY_Phase 1
Recruiting
Window of Opportunity Study of DSP-0390 in Gliomas
Enrollment
20 pts
Location
United States
Sponsor
Washington University School o...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology